On which day of a 28-day menstrual cycle is it best to confirm adenomyosis in a female patient of reproductive age using a scan?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 23, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Optimal Timing for Adenomyosis Diagnosis on Scan

Adenomyosis should be evaluated during the early proliferative phase (days 4-6) of the menstrual cycle when the endometrium is thinnest, allowing for optimal visualization of myometrial features and junctional zone abnormalities. 1

Rationale for Early Proliferative Phase Imaging

  • The endometrium is at its thinnest during days 4-6 of the cycle, which minimizes interference with visualization of the underlying myometrium and junctional zone—the key anatomical areas where adenomyosis manifests 1

  • Endometrial thickness varies significantly throughout the menstrual cycle in premenopausal women, and imaging during other phases may obscure adenomyotic features or create diagnostic confusion 1

  • Transvaginal ultrasound combined with transabdominal approach should be used to fully assess pelvic structures and ensure the endometrium and myometrium are adequately visualized 1

Diagnostic Performance Considerations

  • Transvaginal ultrasound using MUSA criteria demonstrates pooled sensitivity of 82.5% and specificity of 84.6% for adenomyosis diagnosis, making it the first-line imaging modality 2, 1

  • Detection of adenomyosis may be limited if coexisting uterine pathology such as leiomyomas is present, with sensitivity dropping from 97.8% to 33.3% when fibroids are present 1

  • MRI should be considered when ultrasound is inconclusive or adenomyosis obscures endometrial visualization, with MRI demonstrating 78-88% sensitivity and 67-93% specificity 2, 1

Key Imaging Features to Assess

  • Junctional zone thickening and altered appearance are characteristic findings, more commonly seen in older reproductive age women (67.1% in >35 years vs. 39.3% in 18-35 years) 3, 2

  • Focal versus diffuse adenomyosis patterns should be characterized, as diffuse disease is more prevalent in advanced reproductive age (76.7% vs. 39.3% in younger women) 3

  • Myometrial cysts, asymmetric myometrial thickening, and subendometrial echogenic linear striations are additional ultrasound markers to evaluate 4, 5, 6

Common Pitfalls to Avoid

  • Do not accept imaging performed during the secretory phase or menstruation as optimal for adenomyosis diagnosis, as endometrial thickening during these phases obscures myometrial detail 1

  • Approximately 16% of symptomatic patients may not demonstrate direct ultrasound signs despite clinical adenomyosis, requiring integration of clinical context with imaging findings 2

  • Standard pelvic ultrasound protocols do not routinely include the detailed assessment needed to identify adenomyosis features, so ensure the sonographer is specifically evaluating for adenomyosis using MUSA criteria 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Adenomyosis Diagnosis Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Adenomyosis: A Clinical Review of a Challenging Gynecologic Condition.

Journal of minimally invasive gynecology, 2016

Research

An update on adenomyosis.

Diagnostic and interventional imaging, 2013

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.